期刊文献+

抗菌药物耐药机制和抗感染治疗研究进展 被引量:4

下载PDF
导出
摘要 目前临床应用的抗菌药物大部分是在1936~1968年间发现的,过去的40余年仅发现了3种具有新型抗菌作用机制的药物,即利奈唑胺、达托霉素和Mutilins[1]。有限的抗菌药物资源和抗菌药物滥用使得细菌迅速获得耐药性,细菌对抗菌药物的耐药性已成为全球性问题,给抗感染治疗带来了严峻挑战,NDM-1耐药基因的出现更是雪上加霜。
出处 《中国呼吸与危重监护杂志》 CAS 2011年第6期606-610,共5页 Chinese Journal of Respiratory and Critical Care Medicine
基金 科技部十二五"重大新药创制"科技重大专项(编号:2011ZX09302-003-01) 上海市医学会临床医学科研专项基金(编号:SMJ2010005)
  • 相关文献

参考文献28

  • 1Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science ,2009 ,325 : 1089 - 1093.
  • 2Dwyer D J, Kohanski MA, Collins JJ. Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol,2009,12: 482-489.
  • 3Kohanski MA, Dwyer D J, Hayete B, et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 2007,130 : 797-810.
  • 4Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to muttidrug resistance via radical-induced mutagenesis. Mol Cell,2010,37:311-320.
  • 5Ford CB, Lin PL, Chase MR, et al. Use of whole genome sequencing to estimate the mutation rate of mycobacterium tuberculosis during latent infection. Nat Genet,2011,43:482-486.
  • 6Gusarov I, Shatalin K, Starodubtseva M, et al. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science, 2009,325 : 1380-1384.
  • 7Lee HH, Molla MN, Cantor CR,et al. Bacterial charity work leads to population-wide resistance. Nature,2010,467 : 82-85.
  • 8Makarov V, Manina G, Mikusova K, et al. Benzothiazinones kill mycobacterium tuberculosis by blocking arabinan synthesis. Science,2009,324 : 801-804.
  • 9Lin G, lJ D, de Carvalho LPS, et al. Inhibitors selective tbr mycobaeterial versus hmnan proteasomes. Nature,2009,461:621-626.
  • 10Usha V, Gureha SS, Lovering AL, et al. Identification of novel diphenyl urea inhibitors of mt-guab2 active against mycobaeterium tuberculosis. Microbiology,2011,157:290-299.

同被引文献36

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部